Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation
Lynette M. Sholl(Brigham and Women's Hospital), Larissa V. Furtado(St. Jude Children's Research Hospital)
Cited by 35
Related Papers
Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations
|Journal of Thoracic Oncology|2015|132